The Center for Devices and Radiological Health authorized more medical devices in 2023 than at any other time in its 40-year history — excluding emergency use authorizations — and transitioned from its pandemic footing to a more sustainable workload, according to CDRH’s annual report.
“In fact, this was a banner year for the center,” said device centers director Jeff Shuren in the report’s message, which cited the first over-the-counter fentanyl test — Alltest Fentanyl Urine Test
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?